Диссертация (1174209), страница 24
Текст из файла (страница 24)
One view of current status./ KurtzkeJ.F.//Acta Neurol scand. - 1995. – NV 91 – p. 23-33;16021.Гусев Е.И., Бойко А.Н. Рассеянный склероз: достижения десятилетия./ ГусевЕ.И., Бойко А.Н.// Журн.неврол. и психиат. им С.С. Корсакова. – 2007. – N 4 С.4-14;22.Гусев Е.И., Завалишин И.Н., Бойко А.Н., Хорошилова Н.Л. и др..Эпидемиологические характеристики рассеянного склероза в России./ ГусевЕ.И., Завалишин И.Н., Бойко А.Н., Хорошилова Н.Л.
и др..//Журн.неврол. ипсихиат.им. С.С.Корсакова. - 2002. – N 1 – С.3-6;23.Бахтиярова К.З. Рассеянный склероз в республике Башкортостан: клиникоэпидемиологическое и молекулярно-генетическое изучение. автореф.дис.…докт.мед.наук.14.01.11/ Бахтиярова Клара Закиевна.- М, 2007 - 42с;24.Кондратьева О.С., Исмаилов М.Ф., Матвеева Т.В., Саитгалиев И.З. Кэпидемиологии рассеянного склероза на территории Республики Татарстан./Кондратьева О.С., Исмаилов М.Ф., Матвеева Т.В., Саитгалиев И.З.//Неврол.вести. - 2002.
– N 3-4 - С.4-12;25.Фаренбух С.В., Шетекаури С.А. Республиканский регистр рассеянногосклероза в Хакасии./ Фаренбух С.В., Шетекаури С.А.// Нейроиммунология. 2009. - Т.7,N1 - С.99-100;26.ОрловаЮ.Ю.Клинико-патогенетическаягетерогенностьрассеянногосклероза. Автореф.диc. …докт.мед.наук. 14.01.11/Орлова Юлия Юрьевна. –И., 2006 - 43с;27.Якупов Э.З., Матвеева Т.В., Хакимова А.Р., Хафизова И.Ф. Рассеянныйсклероз с поздним дебютом./ Якупов Э.З., Матвеева Т.В., Хакимова А.Р.,Хафизова И.Ф.// Неврологический вестник. - 2010. - N1 - С.66-70;28.Лихачев Д.С. Повесть временных лет.
Русская литература XI—XVIIIвв./ подредакцией Лихачева Д.С.. М.: Худож.лит., 1988 – 462с;29.Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MSin British Columbia, Canada./ Tremlett H, Paty D, Devonshire V.// Neurology. –2005. – N 65(12) – p.1919-1923;16130.Confavreux C, Vukusic S. Reply to: Age at disability milestones in multiplesclerosis and history of multiple sclerosis: a unifying concept./ Confavreux C,Vukusic S.// Brain.
– 2006. – N 129(12) – p. e57-e57;31.Westerlind H. at el.. A significant decrease in diagnosis of primary progressivemultiple sclerosis: A cohort study./ Westerlind H. at el.// Multiple Sclerosis. – 2016.- N 22 – p.1071;32.Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis./ DymentDA, Ebers GC, Sadovnick AD //Lancet Neurol. – 2004. – N 3(92) – p. 104—10;33.Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D et al.. Canadian CollaborativeStudy Group. Twin concordance and sibling recurrence rates in multiple sclerosis./Willer C.J., Dyment D.A., Risch N.J., Sadovnick A.D et al. //Proc.
Natl. Acad. Sci.– 2003. – N 100 - p 12877–12882;34.Jill A. Hollenbach, Jorge R. Oksenberg. The immunogenetics of multiple sclerosis:A comprehensive review./ Jill A. Hollenbach, Jorge R. Oksenberg// Journal ofAutoimmunity. – 2015. - N 64 – p. 13-25;35.Li M.J., Liu Z., Wang P., Wong M.P. et al.. GWASdb v2: an update database forhuman genetic variants identified by genome-wide association studies./ Li M.J., LiuZ., Wang P., Wong M.P. et al..// Nucleic Acids Res. – 2016.
- N 44 – p. D869 –D876;36.Didonna A, Oksenberg JR. Multiple Sclerosis: Perspectives in Treatment andPathogenesis./ Ian S. Zagon and Patricia J. McLaughlin (Editors). The Genetics ofMultiple Sclerosis., 2017 – 16p;37.Bashinskaya V.V., Kulakova O.G., Boyko A.N., Favorov A.V. et al.. A review ofgenome-wide association studies for multiple sclerosis: classical and hypothesisdriven approaches./ Bashinskaya V.V., Kulakova O.G., Boyko A.N., Favorov A.V.et al.// Hum Genet. – 2015. - N 134 – p.1143-1162;38.Greer J.
The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLADRВ 1 chain is associated with the clinical course of multiple sclerosis./ Greer J.//Journal of Neurology, Neurosurgery & Psychiatry. – 2005. – N 76(5) – p.656-662;16239.Jimmy L Huynh, Patrizia Casaccia. Epigenetic mechanisms in multiple sclerosis:implications for pathogenesis and treatment./ Jimmy L Huynh, Patrizia Casaccia.//The Lancet Neurology. – 2013.
- N 12 – p. 195-206;40.Баулина Н.М., Кулакова О.Г., Фаворова О.О.. МикроРНК: роль в развитииаутоиммунного воспаления./ Баулина Н.М., Кулакова О.Г., Фаворова О.О.//Acta Naturae. – 2016. - N 1 – C. 23–36;41.Hohlfeld R, Wekerle H. Autoimmune concepts of multiple sclerosis as a basis forselective immunotherapy: from pipe dreams to (therapeutic) pipelines./ Hohlfeld R,Wekerle H.// Proc Natl Acad Sci USA.
– 2004. – N 101(Suppl 2) – p.14599-606;42.Virtanen JO, Jacobson S. Viruses and Multiple Sclerosis./ Virtanen JO, JacobsonS.// CNS Neurol Disord Drug Targets. – 2012. N 11 – p. 528-544;43.Ascherio A, Munger KL. Epstain Barr virus infection and multiple sclerosis./Ascherio A, Munger KL.// J Neuroimmune Pharmacol. – 2010. – N 5 – p.271-7;44.Lunemann JD, Munz C. EBV in MS:guilty by association?/ Lunemann JD, MunzC.// Trends Immunol. – 2009. – N 30 – p.243-8;45.Maghzi AH, Marta M, Bosca I et al. Viral pathophysiology of multiple sclerosis: arole for Epstain-Barr virus infection?/ Maghzi AH, Marta M, Bosca I et al.//Pathophysiology.
– 2010. – N 18 – p.13-20;46.Salvetti M, Giovannoni G, Aloisi F. Epstain0Barr virus and multiple sclerosis./Salvetti M, Giovannoni G, Aloisi F.//Curr Opin Neurol. – 2009. – N 22 – p.201-6;47.Handel AE, Williamson AJ, Disanto G et al. An up-dated metaanalysis of risk ofmultiple sclerosis following infectious mononucleosis./ Handel AE, Williamson AJ,Disanto G et al.// PloS One. – 2010. – N 5 – p.e12496;48.Levin LI, Munger KL, O’Reilly EJ et al.
Primary infection with Epstain-Barr virusand risk of multiple sclerosis./ Levin LI, Munger KL, O’Reilly EJ et al.// AnnNeurol. – 2010. – N 67 – p 824-30;49.Simon K.C., O’Reilly E.J., Munger Kz.L. et al. Epstain-Barr virus neutralizingantibody levels and risk of multiple sclerosis./ Simon K.C., O’Reilly E.J., MungerKz.L. et al.// Mult.Scler. – 2012. – N 5 – p.30-35;16350.Jaquiery E, Jilek S, Schluep M et al.
Intrathecal immune responses to EBV in earlyMS./ Jaquiery E, Jilek S, Schluep M et al.// Eur J Immunol. – 2010. – N 40 – p.87887;51.Lovato L, Willis SN, Rodig SJ et al. Related B cell clones populate the meningesand parenchyma of patients with multiple sclerosis./ Lovato L, Willis SN, Rodig SJet al.// Brain. – 2011. – N 134 – p.534-41;52.Magliozzi R, Howell OW, Reeves C et al.
A gradient of neuronal loss andmeningeal inflammation in multiple sclerosis./ Magliozzi R, Howell OW, Reeves Cet al.//Ann Neurol. – 2010. – N 68 – p.477-93;53.Magliozzi R, Howell O, Vora A et al. Meningeal B-cell follicles in secondaryprogressive multiple sclerosis associate with early onset of disease and severecortical pathology./ Magliozzi R, Howell O, Vora A et al.// Brain.
– 2007. – N 130 –p.1089-104;54.Tomassini V., Onesti E., Maneiro C et al. Sex hormones modulate brain damage inmultiplesclerosis./TomassiniV.,OnestiE.,ManeiroCetal.//J.Neurol.Neurosurg.Psychiatry. - 2005. – N 76 – p.272-275;55.Glaser R., Padgett D.A., Litsky M.L.et al. Stress-associated changes in the steadystate expression of latent Epstain-Barr virus: implications for chronic fatiguesyndrome and cancer./ Glaser R., Padgett D.A., Litsky M.L.et al.// BrainBehav.Immun. – 2005.
– N 19 – p.91-103;56.Duquette P. Hormonal factors in multiple sclerosis./ Duquette P.// Int MS J. – 2002.– N 9 – p.1-6;57.Гольцова Н.В. Особенности клинической картины и эндокринного статуса уподростков с рассеянным склерозом. Автореф.дис. …канд.мед.наук. 14.00.09,14.00.13/ Гольцова Наталья Викторовна. - М.,2009 - 26 c;58.Azar S.T., Yamout B.
Prolactin secretion is increased in patients with multiplesclerosis./ Azar S.T., Yamout B.// Endocr.Res. – 1999. – N 25 – p.207-214;59.Stadelmann C., Bruck W. Interplay between mechanism of damage and repair inmultiple sclerosis./ Stadelmann C., Bruck W.// J. Neurol. - 2008. – N 255(Suppl.1) –p.12-18;16460.Kremenchutzky M. The natural history of multiple sclerosis: a geographically basedstudy 9: Observations on the progressive phase of the disease./ Kremenchutzky M.//Brain. – 2006. – N 129(3) – p.584-594;61.Revesz T, Kidd D, Thompson A, Barnard R, McDonald W.
A comparison of thepathology of primary and secondary progressive multiple sclerosis./ Revesz T, KiddD, Thompson A, Barnard R, McDonald W.// Brain. – 1994. – N 117(4) – p.759-765;62.Lucchinetti C. A quantitative analysis of oligodendrocytes in multiple sclerosislesions: A study of 113 cases./ Lucchinetti C.// Brain. – 1999. – N 122(12) – p.2279-2295;63.Lucchinetti C, BrпїЅck W, Parisi J, Scheithauer B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
